|
| pct_NEUT neutrophil differential (percentage of viable WBC)
41401
|
Female |
16 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
9 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
16 |
| Male |
16 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
16 |
|
| pct_EOS eosinophil differential (percentage of viable WBC)
41402
|
Female |
16 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
9 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
16 |
| Male |
16 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
16 |
|
| pct_MONO monocyte differential (percentage of viable WBC)
41403
|
Female |
16 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
9 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
16 |
| Male |
16 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
16 |
|
| pct_MONO_inflam inflammatory monocytes (percentage of viable WBC)
41404
|
Female |
16 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
9 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
16 |
| Male |
16 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
16 |
|
| pct_MONO_resident resident monocytes (percentage of viable WBC)
41405
|
Female |
16 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
9 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
16 |
| Male |
16 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
16 |
|
| pct_B_cells B cells (percentage of viable WBC)
41406
|
Female |
16 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
9 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
16 |
| Male |
16 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
16 |
|
| pct_NK_cells natural killer (NK) cells (percentage of viable WBC)
41407
|
Female |
16 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
9 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
16 |
| Male |
16 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
16 |
|
| pct_NK_mature mature natural killer (NK) cells (percentage of viable WBC)
41408
|
Female |
16 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
9 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
16 |
| Male |
16 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
16 |
|
| pct_T_cells T cells (percentage of viable WBC)
41409
|
Female |
16 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
9 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
16 |
| Male |
16 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
16 |
|
| pct_CD4 CD4 T cells (percentage of viable WBC)
41410
|
Female |
16 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
9 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
16 |
| Male |
16 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
16 |
|
| pct_CD8 CD8 T cells (percentage of viable WBC)
41412
|
Female |
16 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
9 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
16 |
| Male |
16 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
8 |
16 |
|
